Wegovy Tablets UK | Oral Semaglutide Weight Loss Pills

Can you buy Wegovy tablets in the UK?

Wegovy tablets have now been approved by the MHRA in the UK. However, they are not yet available to buy, as stock is expected to take a short time to reach UK pharmacies.

Chemist Click expects to offer Wegovy tablets soon through a regulated online consultation, subject to clinical suitability and prescription approval. You can join our waiting list to be notified as soon as Wegovy tablets become available to order.

Wegovy tablets: quick facts

Medication Class	GLP-1 receptor agonist
How Wegovy tablets work	Mimics the natural hormone GLP-1 to reduce appetite, increase feelings of fullness, slow gastric emptying, and improve glucose regulation.
Active ingredient	Semaglutide
Are they the same as Wegovy injections?	They contain the same active ingredient, semaglutide, but are taken daily by mouth instead of once weekly by injection.
UK availability	Yes, subject to stock arriving in the UK
Dosage instructions	Take one tablet daily
Effective within	1-2 weeks: Appetite reduction 4-8 weeks: Noticeable weight loss 3-6 months onwards: Peak clinical effect
Weight loss potential	Clinical trial data showed average weight loss of around 13.6% to 16.6%, depending on treatment adherence
Do they need a prescription?	Yes. A prescription will only be issued after a clinical assessment.

About Wegovy Tablets

What are Wegovy tablets? How they work Results Safety Tablets vs Injections Prices Availability

What are Wegovy tablets?

Wegovy tablets are an oral form of semaglutide designed to support weight loss. They contain the same active ingredient as Wegovy injections, but are taken by mouth instead of injected.

They are taken once daily and work by reducing appetite, increasing feelings of fullness and helping you eat fewer calories over time.

This makes them a potential needle-free alternative for people who want the benefits of semaglutide weight loss treatment without using injections.

How do Wegovy tablets work?

Wegovy tablets contain semaglutide, a GLP-1 receptor agonist.

They work by:

Reducing appetite and increasing feelings of fullness
Slowing stomach emptying, helping you stay satisfied for longer
Lowering cravings and caloric intake
Improving blood-sugar control and insulin sensitivity

An oral (tablet) form delivers semaglutide through the digestive system using absorption-enhancing technology so that enough medication enters the bloodstream to produce the same appetite-regulating effects as weight loss injections.

Wegovy tablets results

Key findings from late-stage studies (e.g., OASIS trials):

In the OASIS 4 trial, Wegovy tablets produced average weight loss of 13.6% using the treatment-policy estimate, and 16.6% in people who stayed on treatment, over 64 weeks
A third of participants lost 20% or more of their starting weight, within the same trial
A substantial proportion of patients achieved between 10-15% weight loss, levels associated with meaningful health benefits.
Appetite reduction and improved portion control were observed early, with progressive weight loss over time.

Further reading: Wegovy tablets results

Wegovy tablets produced weight loss similar to standard Wegovy 2.4mg injections in clinical trial comparisons, although higher-dose injectable Wegovy may produce greater average weight loss.

Are Wegovy tablets safe?

Wegovy tablets contain oral semaglutide, the same active ingredient as Wegovy injections. Clinical trials suggest they have a safety profile broadly similar to injectable Wegovy, with the most common side effects being nausea, vomiting, constipation and diarrhoea.

Most digestive side effects were mild to moderate and improved over time, but Wegovy tablets are not suitable for everyone and should only be used after a clinical assessment.

Wegovy tablets vs injections

Feature	Wegovy Injections	Wegovy Tablets (Oral Semaglutide)
Form	Once-weekly injection	Daily tablet
Availability	Approved and available in the UK	Approved in the UK. Available shortly.
Effectiveness	Around 15% average weight loss with standard 2.4mg dosing; higher-dose Wegovy injections may produce more.	Around 17% average weight loss in trials
Convenience	Weekly dosing, requires injection	No needles; taken by mouth
Onset & consistency	Highly reliable absorption	Absorption can be more variable
Side-effect profile	Similar GLP-1 effects (nausea, GI symptoms)	Similar GLP-1 effects

Further reading: Wegovy tablets vs injections

How much will Wegovy tablets cost in the UK?

Wegovy tablet prices in the UK have not yet been confirmed.

Wegovy tablets have now been approved by the MHRA, but they are not currently available to buy while stock reaches UK pharmacies.

When will Wegovy tablets be available in the UK?

Wegovy tablets have now been approved by the MHRA, but they are not currently available to buy while UK stock is awaited.

Stock is expected to take a few weeks to arrive, although an exact availability date has not yet been confirmed.

Join our waitlist to be among the first to know when Wegovy tablets are available to buy online.

Wegovy tablets dosage

Treatment Phase	Time Period	Dose	Schedule
Starter Dose	Month 1	1.5mg	Once daily
Titration 1	Month 2	4mg	Once daily
Titration 2	Month 3	9mg	Once daily
Maintenance	Month 4 onwards	25mg	Once daily

You begin on a low dose to minimise stomach upset.
The dose is gradually increased over the first three months. Your prescriber may wish to keep you at one dose for longer than a month to allow your body more time to adjust.
From month four, you stay on a maintenance dose designed to give the best balance of appetite control and weight loss.
Tablets would typically be taken once daily, often on an empty stomach with water, to ensure proper absorption.

Further reading: Wegovy tablets dosage

Side effects of Wegovy tablets

Side effects are expected to be similar to injectable semaglutide and other GLP-1 medicines:

Common:

Nausea
Vomiting
Diarrhoea or constipation
Abdominal discomfort
Reduced appetite

Less common but important:

Dehydration (secondary to vomiting/diarrhoea)
Gallbladder issues with rapid weight loss
Rare pancreatitis

Most gastrointestinal symptoms are mild to moderate and improve as the body adapts.

Further reading: Wegovy tablets side effects

Wegovy tablet warnings

Wegovy tablets are not suitable for:

Individuals with a personal or family history of medullary thyroid carcinoma or MEN2
An allergy to semaglutide

Caution should be taken in people with:

Severe gastrointestinal disease
Type 2 diabetes
A history of diabetic retinopathy
A history of mental health concerns
An upcoming surgery where sedation is going to be used

Wegovy tablet interactions

Potential interactions are expected to mirror injectable semaglutide:

Diabetes medications (e.g., insulin, sulfonylureas) may increase the risk of low blood sugar.
Medications requiring rapid absorption may be affected because GLP-1 medicines slow gastric emptying.

Wegovy tablets when pregnant or breastfeeding

Oral Wegovy tablets are not recommended in pregnancy. Weight-loss medicines should be stopped if you are pregnant or planning pregnancy.
Oral Wegovy tablets are not recommended while breastfeeding. There is insufficient safety data regarding exposure to infants.

Frequently Asked Questions

Although Wegovy tablets are now licensed for use in the UK, they cannot be prescribed or supplied until stock becomes available through UK supply channels. This is expected to take a few weeks.

Join our waitlist to be notified as soon as Wegovy tablets are available to order online.

No. You cannot currently buy Wegovy tablets online in the UK, even though they have now been approved by the MHRA. Stock is expected to take a few weeks to arrive, so Wegovy tablets are not yet available to order.

Once UK stock becomes available, Wegovy tablets should only be supplied by regulated pharmacies following an appropriate consultation and prescription approval.

Yes, they were approved by the MHRA on 11th June 2026.

Wegovy tablets have now been approved by the MHRA and are expected to become available in the UK soon. However, there is not yet a confirmed launch date, and stock is expected to take a few weeks to reach UK pharmacies.

Chemist Click will offer Wegovy tablets online once available, subject to stock availability, clinical suitability and prescription approval.

Join our Wegovy tablets waitlist today to be among the first to know when they are available to order.

The UK price of Wegovy tablets has not been confirmed because they are not yet available in the UK.

However, they may be cheaper than Wegovy injections if UK pricing follows the US model, where oral Wegovy launched at a cheaper price than injectable weight loss treatments.

Final UK pricing will depend on approval, supply, dose and pharmacy pricing.

Yes. Wegovy tablets are a form of oral semaglutide.

Semaglutide is the active ingredient in Wegovy, and the tablet version is designed to be taken by mouth rather than injected. It works by mimicking the GLP-1 hormone, helping reduce appetite, increase fullness and support weight loss.

No. Wegovy tablets and Rybelsus both contain oral semaglutide, but they are not the same treatment.

Rybelsus is licensed for type 2 diabetes, not weight loss, and is available in lower doses.

Wegovy tablets are higher-dose oral semaglutide tablets developed specifically for weight management in countries where they are approved.

Wegovy tablets contain oral semaglutide, while orforglipron is a different oral GLP-1 tablet being developed by Eli Lilly.

Both are tablets designed to support weight loss, but they contain different active ingredients.

Wegovy tablets appear to offer weight loss results broadly comparable with standard Wegovy 2.4mg injections, although they have not been directly compared in a head-to-head UK trial.

In the OASIS 4 trial, Wegovy tablets produced average weight loss of 16.6% in people who stayed on treatment. However, higher-dose Wegovy injections may produce greater average weight loss in some patients.

In the OASIS 4 trial, people taking Wegovy tablets lost an average of 16.6% of their body weight when they stayed on treatment.

Around one in three people lost 20% or more of their body weight. Individual results can vary depending on dose, diet, activity levels, side effects, treatment adherence and starting weight.

Yes. If Wegovy tablets are approved in the UK, they will require a prescription.

They should only be supplied after a clinical consultation to check whether treatment is suitable and safe. You should not buy Wegovy tablets from unregulated websites, social media sellers or marketplaces.

You can join the Wegovy tablets waiting list by entering your details on the Chemist Click Wegovy tablets page.

We will let you know when Wegovy tablets become available in the UK. Treatment will only be supplied after a consultation has been assessed and approved by one of our pharmacists.

UK registered online pharmacy
Pharmacist-led weight loss service
Regulated prescription process
Clinical suitability checks
Ongoing weight loss support
Discreet delivery
Verified reviews
No unlicensed or counterfeit medicines

Authored by

Abbas Kanani

Superintendent Pharmacist

Written by Chemist Click

First created 7th May 2026

Last reviewed 11th June 2026

Wegovy Tablets UK Oral Semaglutide Weight Loss Pills

Join Wegovy Tablets Waiting List